We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Eurofins to Acquire Genetic Testing Services Provider DNA Diagnostics Center

By LabMedica International staff writers
Posted on 29 Jun 2021
Eurofins Scientific (Ebersberg, Germany) has announces that its subsidiary Eurofins Clinical Testing US Holdings, Inc. has entered into an agreement to acquire DNA Diagnostics Center (DDC; Fairfield, OH, USA).

DDC is one of the most highly accredited genetic-testing laboratories in the world and was founded on the premise that the technological advancements in DNA testing should translate into services that are accessible and affordable to everyone. The company provides comprehensive consumer and legal DNA testing services for paternity and family relationships, fertility, lifestyle, veterinary, and forensics. DDC is an established and trusted consumer focused testing laboratory, with an extensive and global distribution network.

Illustration
Illustration

Eurofins believes that consumer genetic testing, to support personalized lifestyle and health awareness is a significant growth opportunity, and this acquisition will support and significantly accelerate Eurofins’ strategy to expand further into this market. DDC has a highly successful and growing test and product menu and will benefit from Eurofins access to additional markets. We also expect leverage from DDC distribution and sales of existing Eurofins testing capabilities into the consumer market for both genetic and other health and wellness related tests.

Related Links:
Eurofins Scientific
DNA Diagnostics Center



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Steam Sterilizer
Hi Vac II Line
New
Automatic CLIA Analyzer
Shine i6000

Latest Industry News

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio
29 Jun 2021  |   Industry

FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy
29 Jun 2021  |   Industry

CareDx Expands Precision Oncology Portfolio with Naveris Acquisition
29 Jun 2021  |   Industry



ADLM